Michael Ohh

14.9k total citations · 3 hit papers
99 papers, 11.2k citations indexed

About

Michael Ohh is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael Ohh has authored 99 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 72 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Michael Ohh's work include Cancer, Hypoxia, and Metabolism (67 papers), Ubiquitin and proteasome pathways (20 papers) and RNA modifications and cancer (16 papers). Michael Ohh is often cited by papers focused on Cancer, Hypoxia, and Metabolism (67 papers), Ubiquitin and proteasome pathways (20 papers) and RNA modifications and cancer (16 papers). Michael Ohh collaborates with scholars based in Canada, United States and Japan. Michael Ohh's co-authors include William G. Kaelin, Mircea Ivan, Keiichi Kondo, William S. Lane, William Kim, Adrian Salic, John M. Asara, Haifeng Yang, Mindy A. Maynard and Vincent Chau and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael Ohh

96 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O ₂ Sensing

2001 3.9k citations Michael Ohh, William G. Kaelin et al. profile →
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

2000 1.3k citations Michael Ohh, Nikola P. Pavletich et al. profile →
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix

1998 395 citations Michael Ohh, William G. Kaelin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Ohh Canada	44	7.7k	6.9k	1.7k	1.4k	1.4k	99	11.2k
Mircea Ivan United States	37	8.3k 1.1×	8.3k 1.2×	1.3k 0.7×	1.4k 1.0×	922 0.7×	80	11.9k
Panu Jaakkola Finland	28	6.4k 0.8×	7.0k 1.0×	1.0k 0.6×	1.7k 1.2×	900 0.7×	64	10.2k
David R. Mole United Kingdom	41	9.0k 1.2×	9.8k 1.4×	1.2k 0.7×	2.2k 1.6×	1.5k 1.1×	69	14.1k
Brian Keith United States	44	7.5k 1.0×	6.8k 1.0×	3.4k 2.0×	1.7k 1.2×	1.3k 1.0×	65	13.7k
Eric Huang United States	38	6.2k 0.8×	6.1k 0.9×	1.3k 0.7×	1.4k 1.0×	688 0.5×	99	10.0k
Ya‐Min Tian United Kingdom	25	7.1k 0.9×	8.1k 1.2×	846 0.5×	2.0k 1.4×	752 0.6×	32	11.2k
Othon Iliopoulos United States	35	5.9k 0.8×	4.8k 0.7×	1.4k 0.8×	524 0.4×	1.5k 1.1×	94	8.9k
Michael I. Lerman United States	61	10.2k 1.3×	4.3k 0.6×	2.6k 1.5×	1.6k 1.1×	2.9k 2.1×	165	14.5k
Alex von Kriegsheim United Kingdom	38	5.8k 0.8×	4.0k 0.6×	1.3k 0.7×	1.1k 0.8×	631 0.5×	120	9.2k
Edurne Berra France	43	6.0k 0.8×	4.7k 0.7×	1.1k 0.6×	1.1k 0.8×	473 0.3×	69	9.4k

Countries citing papers authored by Michael Ohh

Since Specialization

Citations

This map shows the geographic impact of Michael Ohh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ohh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ohh more than expected).

Fields of papers citing papers by Michael Ohh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ohh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ohh. The network helps show where Michael Ohh may publish in the future.

Co-authorship network of co-authors of Michael Ohh

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ohh. A scholar is included among the top collaborators of Michael Ohh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ohh. Michael Ohh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stuart, Sarah, et al.. (2024). Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavage. Scientific Reports. 14(1). 14799–14799.

Yu, Pei, Hisham M. Ibrahim, Corey A. Scipione, et al.. (2023). Oxidized Low-Density Lipoprotein Accumulation Suppresses Glycolysis and Attenuates the Macrophage Inflammatory Response by Diverting Transcription from the HIF-1α to the Nrf2 Pathway. The Journal of Immunology. 211(10). 1561–1577. 15 indexed citations

Robinson, Claire M., et al.. (2020). NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma. Cancer Research. 80(16). 3413–3423. 47 indexed citations

Lee, Jeffrey E., et al.. (2019). Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α. Nature Communications. 10(1). 3293–3293. 20 indexed citations

Robinson, Claire M., François Lefebvre, Betty Poon, et al.. (2018). Consequences of VHL Loss on Global DNA Methylome. Scientific Reports. 8(1). 3313–3313. 12 indexed citations

Ohh, Michael, et al.. (2017). The HIF and other quandaries in VHL disease. Oncogene. 37(2). 139–147. 60 indexed citations

Heir, Pardeep, Tharan Srikumar, George Bikopoulos, et al.. (2016). Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling. Journal of Biological Chemistry. 291(14). 7357–7372. 25 indexed citations

Robinson, Claire M. & Michael Ohh. (2014). The multifaceted von Hippel–Lindau tumour suppressor protein. FEBS Letters. 588(16). 2704–2711. 70 indexed citations

Bunda, Severa, Michelle Kang, Stephanie S. Sybingco, et al.. (2013). Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia. Cancer Research. 73(8). 2540–2550. 22 indexed citations

10.

Ho, Jacqueline, Julie Metcalf, Matthew S. Yan, et al.. (2012). Functional Importance of Dicer Protein in the Adaptive Cellular Response to Hypoxia. Journal of Biological Chemistry. 287(34). 29003–29020. 130 indexed citations

11.

Olsson, Anna, H. Zhong, Rong Wang, et al.. (2010). Pediatrics. Modern Pathology. 23. 393–396. 1 indexed citations

12.

Roberts, Andrew M., Ian R. Watson, Andrew Evans, et al.. (2009). Suppression of Hypoxia-Inducible Factor 2α Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells. Cancer Research. 69(23). 9056–9064. 67 indexed citations

13.

Toschi, Alfredo, Evan Lee, Noga Gadir, Michael Ohh, & David A. Foster. (2008). Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2. Journal of Biological Chemistry. 283(50). 34495–34499. 239 indexed citations

14.

Koeman, Julie, Ryan C. Russell, Min‐Han Tan, et al.. (2008). Correction: Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated EGLN2-Mediated Oxygen-Sensing Response. PLoS Genetics. 4(9). 3 indexed citations

15.

Fish, Jason E., et al.. (2007). Hypoxia-inducible Expression of a Natural cis-Antisense Transcript Inhibits Endothelial Nitric-oxide Synthase. Journal of Biological Chemistry. 282(21). 15652–15666. 118 indexed citations

16.

Maynard, Mindy A., et al.. (2005). Human HIF‐3α4 is a dominant‐negative regulator of HIF‐1 and is down‐regulated in renal cell carcinoma. The FASEB Journal. 19(11). 1396–1406. 161 indexed citations

17.

Ohh, Michael, et al.. (2005). Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway. Current Cancer Drug Targets. 5(5). 345–356. 16 indexed citations

18.

Maynard, Mindy A., Heng Qi, Jacky Chung, et al.. (2003). Multiple Splice Variants of the Human HIF-3α Locus Are Targets of the von Hippel-Lindau E3 Ubiquitin Ligase Complex. Journal of Biological Chemistry. 278(13). 11032–11040. 223 indexed citations

19.

Ohh, Michael, et al.. (1999). The von Hippel–Lindau tumour suppressor protein: new perspectives. Molecular Medicine Today. 5(6). 257–263. 61 indexed citations

20.

Ohh, Michael, Yuichiro Takagi, Teijiro Aso, et al.. (1999). Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. Journal of Clinical Investigation. 104(11). 1583–1591. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact